Researchers have zeroed in on yet another possible ocular concern for diabetes patients who take popular GLP-1 therapies in a ...

In its continued bid to waylay the launch of MSN Pharmaceuticals’ proposed Entresto generic, Novartis has told a federal ...

Days after FDA Commissioner Marty Makary said that the agency planned to review the safety of abortion pill mifepristone, ...

The PD-(L)1xVEGF field had a roller coaster week marked by an imperfect readout and a potentially $11 billion deal. | The PD- ...

Each year, the American Society of Clinical Oncology annual meeting brings together the biggest names and brightest minds in ...

Argenx has signed on as an early partner to a newly launched initiative from media companies NBCUniversal Local and Digital ...

Amneal Pharmaceuticals is recalling three lots of sulfamethoxazole/trimethoprim tablets because of microbial contamination ...

A little less than a year after cutting the ribbon at a new glass syringe factory in Hungary, Schott Pharma is making good on ...

Bayer has taken another step toward achieving its €3 billion peak sales estimate for androgen receptor inhibitor Nubeqa, ...

Orca Bio is preparing to make a splash in the cell therapy market. | Orca Bio is preparing to make a splash in the cell ...

Drugmakers and contract manufacturers are responding to the booming demand for antibody-drug conjugates, with multiple ...

After a long winter, the start of summer is ushering in some much-needed sunshine, warmer weather and, for a handful of ...